Want to see HK:1501 full AI Analyst Report?
Shanghai Kindly Medical Instruments Co., Ltd. Class H (1501) Ratios
Shanghai Kindly Medical Instruments Co., Ltd. Class H Ratios
HK:1501's free cash flow for Q2 2026 was $165.20M. For the 2026 fiscal year, HK:1501's free cash flow was decreased by $-57.11M and operating cash flow was $222.31M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.26 | 2.05 | 2.29 | 3.35 | 5.60 |
| Quick Ratio | 1.02 | 1.68 | 1.88 | 2.70 | 5.00 |
| Cash Ratio | 0.75 | 1.20 | 1.34 | 2.16 | 4.18 |
| Solvency Ratio | 0.31 | 0.50 | 0.58 | 0.59 | 0.91 |
| Operating Cash Flow Ratio | 0.42 | 0.52 | 0.56 | 0.75 | 0.47 |
| Short-Term Operating Cash Flow Coverage | 0.65 | 0.99 | 2.25 | 5.52 | 0.00 |
| Net Current Asset Value | $ -20.95M | $ 418.74M | $ 373.04M | $ 528.71M | $ 674.81M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.23 | 0.11 | 0.05 | 0.03 | 0.01 |
| Debt-to-Equity Ratio | 0.36 | 0.14 | 0.06 | 0.03 | 0.01 |
| Debt-to-Capital Ratio | 0.26 | 0.12 | 0.05 | 0.03 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.57 | 1.27 | 1.23 | 1.21 | 1.16 |
| Debt Service Coverage Ratio | 0.62 | 1.01 | 2.48 | 4.46 | 242.59 |
| Interest Coverage Ratio | 21.64 | 88.97 | 55.83 | 177.61 | 246.96 |
| Debt to Market Cap | 0.15 | 0.05 | 0.02 | 0.01 | 0.00 |
| Interest Debt Per Share | 4.23 | 1.41 | 0.57 | 0.30 | 0.08 |
| Net Debt to EBITDA | 0.29 | -1.09 | -1.46 | -2.93 | -3.72 |
| Profitability Margins | |||||
| Gross Profit Margin | 59.77% | 63.11% | 58.19% | 56.75% | 59.34% |
| EBIT Margin | 24.24% | 24.96% | 23.69% | 22.08% | 31.13% |
| EBITDA Margin | 34.02% | 29.98% | 30.00% | 27.31% | 36.33% |
| Operating Profit Margin | 25.48% | 25.38% | 23.69% | 24.80% | 33.64% |
| Pretax Profit Margin | 24.24% | 25.05% | 23.26% | 24.66% | 33.51% |
| Net Profit Margin | 20.53% | 22.53% | 20.78% | 22.48% | 30.77% |
| Continuous Operations Profit Margin | 21.84% | 22.31% | 20.35% | 22.84% | 30.22% |
| Net Income Per EBT | 84.70% | 89.94% | 89.34% | 91.17% | 91.82% |
| EBT Per EBIT | 95.16% | 98.69% | 98.21% | 99.44% | 99.60% |
| Return on Assets (ROA) | 6.98% | 8.49% | 7.71% | 7.21% | 8.82% |
| Return on Equity (ROE) | 10.96% | 10.82% | 9.49% | 8.71% | 10.24% |
| Return on Capital Employed (ROCE) | 11.69% | 11.84% | 10.41% | 9.15% | 10.65% |
| Return on Invested Capital (ROIC) | 8.58% | 9.38% | 8.71% | 8.89% | 10.02% |
| Return on Tangible Assets | 9.17% | 9.18% | 7.79% | 7.24% | 8.85% |
| Earnings Yield | 4.72% | 4.04% | 3.53% | 3.10% | 4.60% |
| Efficiency Ratios | |||||
| Receivables Turnover | 9.50 | 7.17 | 6.01 | 7.91 | 5.84 |
| Payables Turnover | 6.77 | 7.11 | 9.58 | 6.97 | 7.05 |
| Inventory Turnover | 2.20 | 1.94 | 2.44 | 1.64 | 2.04 |
| Fixed Asset Turnover | 1.13 | 0.93 | 0.84 | 0.78 | 0.82 |
| Asset Turnover | 0.34 | 0.38 | 0.37 | 0.32 | 0.29 |
| Working Capital Turnover Ratio | 3.18 | 1.97 | 1.55 | 0.92 | 0.56 |
| Cash Conversion Cycle | 150.64 | 188.10 | 171.92 | 215.98 | 189.40 |
| Days of Sales Outstanding | 38.43 | 50.93 | 60.70 | 46.15 | 62.51 |
| Days of Inventory Outstanding | 166.10 | 188.53 | 149.32 | 222.22 | 178.69 |
| Days of Payables Outstanding | 53.88 | 51.36 | 38.10 | 52.40 | 51.80 |
| Operating Cycle | 204.53 | 239.46 | 210.02 | 268.37 | 241.20 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.98 | 1.29 | 1.04 | 1.08 | 0.44 |
| Free Cash Flow Per Share | 1.61 | 0.34 | -0.31 | -0.38 | -1.24 |
| Dividend Paid and CapEx Coverage Ratio | 5.43 | 1.06 | 0.66 | 0.63 | 0.22 |
| Capital Expenditure Coverage Ratio | 5.43 | 1.36 | 0.77 | 0.74 | 0.26 |
| Operating Cash Flow Coverage Ratio | 0.48 | 0.93 | 1.88 | 3.70 | 5.43 |
| Operating Cash Flow to Sales Ratio | 0.32 | 0.26 | 0.24 | 0.31 | 0.16 |
| Free Cash Flow Yield | 6.00% | 1.26% | -1.20% | -1.48% | -6.60% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 21.37 | 24.72 | 28.30 | 32.24 | 21.75 |
| Price-to-Sales (P/S) Ratio | 4.35 | 5.57 | 5.88 | 7.25 | 6.69 |
| Price-to-Book (P/B) Ratio | 2.32 | 2.67 | 2.68 | 2.81 | 2.23 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 16.67 | 79.34 | -83.47 | -67.67 | -15.16 |
| Price-to-Operating Cash Flow Ratio | 13.60 | 21.04 | 24.86 | 23.53 | 42.74 |
| Price-to-Earnings Growth (PEG) Ratio | 1.13 | 1.05 | 2.24 | -3.96 | 1.22 |
| Enterprise Value Multiple | 13.09 | 17.49 | 18.15 | 23.61 | 14.70 |
| Enterprise Value | 4.74B | 4.47B | 4.10B | 3.78B | 2.48B |
| EV to EBITDA | 13.09 | 17.49 | 18.15 | 23.61 | 14.70 |
| EV to Sales | 4.45 | 5.24 | 5.44 | 6.45 | 5.34 |
| EV to Free Cash Flow | 17.05 | 74.69 | -77.27 | -60.19 | -12.10 |
| EV to Operating Cash Flow | 13.91 | 19.80 | 23.01 | 20.93 | 34.12 |
| Tangible Book Value Per Share | 7.78 | 9.27 | 9.70 | 9.25 | 8.62 |
| Shareholders’ Equity Per Share | 11.59 | 10.17 | 9.65 | 9.04 | 8.41 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.10 | 0.11 | 0.13 | 0.07 | 0.10 |
| Revenue Per Share | 6.19 | 4.88 | 4.41 | 3.50 | 2.80 |
| Net Income Per Share | 1.27 | 1.10 | 0.92 | 0.79 | 0.86 |
| Tax Burden | 0.85 | 0.90 | 0.89 | 0.91 | 0.92 |
| Interest Burden | 1.00 | 1.00 | 0.98 | 1.12 | 1.08 |
| Research & Development to Revenue | 0.14 | 0.18 | 0.17 | 0.17 | 0.19 |
| SG&A to Revenue | 0.25 | 0.23 | 0.13 | 0.11 | 0.11 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| Income Quality | 1.56 | 1.06 | 1.02 | 1.37 | 0.51 |
Currency in CNY